Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study)
Clinical trial NCT04679909 · COMPLETED
Trial details
- NCT number
- NCT04679909
- Sponsor
- Altimmune, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-25
- Primary completion
- 2021-12-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.